[
    [
        {
            "time": "",
            "original_text": "基因测序双周榜：药明康德触底反弹“王者归来”？国际医学迎明星基金经理调研",
            "features": {
                "keywords": [
                    "基因测序",
                    "药明康德",
                    "触底反弹",
                    "国际医学",
                    "明星基金经理",
                    "调研"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "基因测序双周榜：药明康德触底反弹“王者归来”？国际医学迎明星基金经理调研",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "利润环比连增+同比暴增112匹盈利白马现身",
            "features": {
                "keywords": [
                    "利润",
                    "环比增长",
                    "同比增长",
                    "盈利白马"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "全行业"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "利润环比连增+同比暴增112匹盈利白马现身",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "“A股医药一哥”换了：迈瑞医疗市值反超恒瑞医药",
            "features": {
                "keywords": [
                    "A股医药",
                    "迈瑞医疗",
                    "恒瑞医药",
                    "市值反超"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "“A股医药一哥”换了：迈瑞医疗市值反超恒瑞医药",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        }
    ]
]